Package 54092-063-01

Brand: agrylin

Generic: anagrelide hydrochloride
NDC Package

Package Facts

Identity

Package NDC 54092-063-01
Digits Only 5409206301
Product NDC 54092-063
Product ID 54092-063_06f9dfa4-c90a-4636-b3b1-79b488815bb3
Description

100 CAPSULE in 1 BOTTLE (54092-063-01)

Marketing

Marketing Status
Marketed Since 1997-03-14
Brand agrylin
Generic anagrelide hydrochloride
Sample Package No

Linked Drug Pages (1)

Agrylin ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "06f9dfa4-c90a-4636-b3b1-79b488815bb3", "openfda": {"upc": ["0354092063017"], "unii": ["VNS4435G39"], "rxcui": ["597850", "597857"], "spl_set_id": ["cb960074-99c1-4a73-941f-f0644a7ec219"], "manufacturer_name": ["Takeda Pharmaceuticals America, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (54092-063-01)", "package_ndc": "54092-063-01", "marketing_start_date": "19970314"}], "brand_name": "Agrylin", "product_id": "54092-063_06f9dfa4-c90a-4636-b3b1-79b488815bb3", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Platelet Production [PE]", "Phosphodiesterase 3 Inhibitors [MoA]", "Platelet-reducing Agent [EPC]"], "product_ndc": "54092-063", "generic_name": "anagrelide hydrochloride", "labeler_name": "Takeda Pharmaceuticals America, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Agrylin", "active_ingredients": [{"name": "ANAGRELIDE HYDROCHLORIDE ANHYDROUS", "strength": ".5 mg/1"}], "application_number": "NDA020333", "marketing_category": "NDA", "marketing_start_date": "19970314", "listing_expiration_date": "20261231"}